FDA advisory panel recommends approval of Pfizer Covid vaccine for emergency use

Recommendation signals formal FDA approval for Pfizer/BioNTech vaccine in the US could be imminent

An advisory panel to the US Food and Drug Administration has recommended the emergency approval of a Covid-19 vaccine developed by Pfizer and BioNTech.

The recommendation is expected to signal that the first approval of a Covid-19 vaccine for use in the US is imminent. That would mark a major milestone in a pandemic that has killed more than 285,000 Americans and 1.5 million people globally.